All Stories

  1. Acceptability and feasibility of one-stop home-based genital self-sampling for female genital schistosomiasis, human papilloma virus and self-testing for trichomonas and HIV: the Zipime Weka Schista study in Zambia
  2. Schistosomal circulating anodic antigen dynamics pre- and post-treatment in preschool aged children from the PIP trial in Uganda
  3. Exploring the potential association of intestinal schistosomiasis and environmental enteric dysfunction
  4. Female genital schistosomiasis: hidden in plain sight
  5. Schistosoma mansoni infection is associated with changes in gut microbiota in preschool age children in Albertine Region, Uganda
  6. Schistosomiasis and childhood stunting
  7. Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections
  8. TRPtracker: a community database for monitoring praziquantel sensitivity at TRPMPZQ variants
  9. Association between female genital schistosomiasis and high-risk human papillomavirus among women of reproductive age in Zambia: the Schista study
  10. Acceptability and feasibility of one-stop home-based genital self-sampling for Female Genital Schistosomiasis, Human Papilloma Virus and self- testing for Trichomonas and HIV: The Zipime Weka Schista Study in Zambia
  11. Finding hybrid schistosomes in genital schistosomiasis: are we missing their clinical relevance?
  12. Association between female genital schistosomiasis and high-risk human papillomavirus among women of reproductive age in Zambia: the Schista study
  13. Isothermal Recombinase Polymerase Amplification based diagnostics for Female Genital Schistosomiasis and Human Papillomavirus: A Review of Combined Molecular Diagnostic Opportunities
  14. Visual diagnostics for female genital schistosomiasis and the opportunity for improvement using computer vision
  15. TRPtracker: a community database for monitoring praziquantel sensitivity at TRPMPZQ variants
  16. Community-based serological screening for Chagas disease in London: a cross-sectional, observational pilot study
  17. Closing the diagnostic gap in male genital schistosomiasis (MGS): current detection tools and novel strategies
  18. ‘Female Genital Schistosomiasis: Translational Challenges and Opportunities’ – outputs and actions from a consultative, collaborative and translational workshop
  19. Schistosomiasis
  20. Safety and efficacy of praziquantel 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis in Uganda: a 2 × 2 factorial, double-blind, placebo-controlled, phase 2 randomised trial
  21. The first BILGENSA Research Network workshop in Zambia: identifying research priorities, challenges and needs in genital bilharzia in Southern Africa
  22. Point-of-care ultrasound reveals extensive pathology in Gabonese preschool-age children with urogenital schistosomiasis
  23. Protecting global health partnerships in the era of destructive nationalism
  24. Towards multilingualism in global health
  25. Female Genital Schistosomiasis (FGS) in a Nonendemic Setting: Retrospective Case-Notes Review of Schistosoma haematobium–Positive FGS Cases at the Hospital for Tropical Diseases, London, With a Pragmatic Clinical Pathway for Nonendemic Settings
  26. Landscape of guidance documents used at TropNet and GeoSentinel centres for the clinical management of schistosomiasis outside endemic areas: A systematic appraisal
  27. Description of four cases of male genital schistosomiasis (MGS) in children and adolescents, with a scoping review
  28. Association of female genital schistosomiasis and human papillomavirus and cervical pre-cancer: a systematic review
  29. Phase II Factorial Randomised Double Blinded Placebo-Controlled Trial of Praziquantel 40 mg/kg vs 80 mg/kg in Preschool Children with Intestinal Schistosomiasis in Uganda
  30. Urogenital Schistosoma haematobium Cases at the Hospital for Tropical Diseases, London (1998-2018), and Suggested Pragmatic Follow-up Pathway for Non-endemic Settings
  31. Associations of poor water, sanitation, and hygiene and parasite burden with markers of environmental enteric dysfunction in preschool‐age children infected with Schistosoma mansoni in Uganda
  32. Combined interventions for the testing and treatment of HIV and schistosomiasis among fishermen in Malawi: a three-arm, cluster-randomised trial
  33. A health decision analytical model to evaluate the cost‐effectiveness of female genital schistosomiasis screening strategies: The female genital schistosomiasis SCREEN framework
  34. Correction to: The Presence of Hemoglobin in Cervicovaginal Lavage Is Not Associated With Genital Schistosomiasis in Zambian Women From the BILHIV Study
  35. The first BILGENSA Research Network workshop in Zambia: identifying research priorities, challenges and needs in genital bilharzia in Southern Africa
  36. Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and H...
  37. Female genital schistosomiasis burden and risk factors in two endemic areas in Malawi nested in the Morbidity Operational Research for Bilharziasis Implementation Decisions (MORBID) cross-sectional study
  38. Female genital schistosomiasis is a women’s issue, but men should not be left out: involving men in promoting care for female genital schistosomiasis in mainland Tanzania
  39. A cross‐sectional pilot household study of Schistosoma mansoni burden and associated morbidities in Lake Albert, Uganda
  40. Time to bring female genital schistosomiasis out of neglect
  41. Female Genital Schistosomiasis Lesion Resolution Post-Treatment with Praziquantel in Zambian Adults
  42. Schistosomiasis
  43. Building Partnerships to Empower Women Through Home Self-Sampling for Sexual and Reproductive Tract Infections
  44. Lakeside Combined HIV Testing Including Self-Testing with ART Referral and Presumptive Schistosomiasis Treatment Through Beach Clinics Targeting Malawian Fisherman: A Cluster Randomized Trial Comparing 28-Day Outcomes Under 3 Intervention Strategies
  45. Phase Ii Randomised Double Blinded Placebo-Controlled Trial of Praziquantel 40 mg/kg vs 80 mg/kg in Preschool Children with Intestinal Schistosomiasis in Uganda
  46. Baseline Liver Ultrasound Findings in Preschool Children From the Praziquantel in Preschoolers Trial in Lake Albert, Uganda
  47. The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
  48. Relationships Between Schistosoma Mansoni Infection Intensity and Nutritional Status and Anemia Among Preschool-aged Children in Uganda
  49. An Update on Schistosomiasis
  50. Visual diagnosis of female genital schistosomiasis in Zambian women from hand-held colposcopy: agreement of expert image review and association with clinical symptoms
  51. Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022
  52. A 14-year follow-up of ultrasound-detected urinary tract pathology associated with urogenital schistosomiasis in women living in the Msambweni region of coastal Kenya
  53. Visual diagnosis of female genital schistosomiasis in Zambian women from hand-held colposcopy: agreement of expert image review
  54. The Presence of Hemoglobin in Cervicovaginal Lavage Is Not Associated With Genital Schistosomiasis in Zambian Women From the BILHIV Study
  55. A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: Is praziquantel and intestinal schistosomiasis a perfect match?
  56. Validation of the isothermal Schistosoma haematobium Recombinase Polymerase Amplification (RPA) assay, coupled with simplified sample preparation, for diagnosing female genital schistosomiasis using cervicovaginal lavage and vaginal self-swab samples
  57. Impact of a Novel, Low-Cost and Sustainable Health Education Program on the Knowledge, Attitudes, and Practices Related to Intestinal Schistosomiasis in School Children in a Hard-to-Reach District of Madagascar
  58. An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: The time is now
  59. The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
  60. The challenges for women’s health in sub-Saharan Africa: Lessons learned from an integrative multistakeholder workshop in Gabon
  61. Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised contr...
  62. Association of Female Genital Schistosomiasis With the Cervicovaginal Microbiota and Sexually Transmitted Infections in Zambian Women
  63. Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women
  64. Female Genital Schistosomiasis and HIV-1 Incidence in Zambian Women: A Retrospective Cohort Study
  65. Prevalence of intestinal schistosomiasis in pre-school aged children: a pilot survey in Marolambo District, Madagascar
  66. Five-Year Follow-Up on the Prevalence and Intensity of Infections of Schistosoma mansoni in a Hard-to-Reach District of Madagascar
  67. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis
  68. Malaria and helminth co-infections in children living in endemic countries: A systematic review with meta-analysis
  69. Promoting gender, equity, human rights and ethnic equality in neglected tropical disease programmes
  70. Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.
  71. Use of facemasks and other personal preventive measures by Hajj pilgrims and their impact on health problems during the Hajj
  72. Acceptability and feasibility of genital self-sampling for the diagnosis of female genital schistosomiasis: a cross-sectional study in Zambia
  73. Correction: Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
  74. Intestinal Schistosomiasis and Giardiasis Co-Infection in Sub-Saharan Africa: Can a One Health Approach Improve Control of Each Waterborne Parasite Simultaneously?
  75. Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study
  76. Intestinal Schistosomiasis and Giardiasis Co-Infection in Sub-Saharan Africa: Can a One Health Approach Improve Control of Each Waterborne Parasite Simultaneously?
  77. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
  78. Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer
  79. Application of a recombinase polymerase amplification (RPA) assay and pilot field testing for Giardia duodenalis at Lake Albert, Uganda
  80. Could This Child Have Schistosomiasis?
  81. Beyond the barrier: Female Genital Schistosomiasis as a potential risk factor for HIV-1 acquisition
  82. Acceptability and feasibility of genital self-sampling for the diagnosis of female genital schistosomiasis: a cross-sectional study in Zambia
  83. A cross-sectional study of periportal fibrosis and Schistosoma mansoni infection among school-aged children in a hard-to-reach area of Madagascar
  84. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review
  85. Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS)—pilot evaluation of a simple point-of-care ultrasound protocol and short training program for detecting urinary tract morbidity in highly endemic settings
  86. Implementation of a Highly Accurate Rapid Point-of-Care Test for Group a Streptococcus Detection at a Large Pediatric Emergency Department in South London
  87. Schistosoma mansoni Infection as a Predictor of Low Aerobic Capacity in Ugandan Children
  88. Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
  89. Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control
  90. Cognitive deficits and educational loss in children with schistosome infection—A systematic review and meta-analysis
  91. Praziquantel for the treatment of schistosomiasis during human pregnancy
  92. Paediatric and maternal schistosomiasis: shifting the paradigms
  93. High burden of Schistosoma mansoni infection in school-aged children in Marolambo District, Madagascar
  94. Point-of-care tests for infectious diseases: barriers to implementation across three London teaching hospitals
  95. One hundred years of neglect in paediatric schistosomiasis
  96. A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now
  97. Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
  98. Predictors of fever-related admissions to a paediatric assessment unit, ward and reattendances in a South London emergency department: the CABIN 2 study
  99. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
  100. A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases
  101. Point-of-Care Ultrasound Assessment of Tropical Infectious Diseases—A Review of Applications and Perspectives
  102. Anemia Among Children Exposed to Polyparasitism in Coastal Kenya
  103. Age-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections
  104. Endomyocardial Fibrosis (EMF) in a Ugandan Child with Advanced Hepatosplenic Schistosomiasis: Coincidence or Connection?
  105. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination
  106. Cross-sectional Study of the Burden of Vector-Borne and Soil-Transmitted Polyparasitism in Rural Communities of Coast Province, Kenya
  107. HIV and schistosomiasis co-infection in African children
  108. Human schistosomiasis
  109. Parasitic Helminths
  110. Development of a Specimen-Sparing Multichannel Bead Assay to Detect Antiparasite IgG4 for the Diagnosis of Schistosoma and Wuchereria Infections on the Coast of Kenya
  111. Preventive chemotherapy for schistosomiasis and soil-transmitted helminthiasis by cotreatment with praziquantel and albendazole
  112. Schistosomiasis
  113. Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
  114. Schistosomiasis in African infants and preschool children: let them now be treated!
  115. Evaluation of the Health-related Quality of Life of Children in Schistosoma haematobium-endemic Communities in Kenya: A Cross-sectional Study
  116. Impact of Polyparasitic Infections on Anemia and Undernutrition among Kenyan Children Living in a Schistosoma haematobium-Endemic Area
  117. Impact of Drought on the Spatial Pattern of Transmission of Schistosoma haematobium in Coastal Kenya
  118. Measuring Fitness of Kenyan Children with Polyparasitic Infections Using the 20-Meter Shuttle Run Test as a Morbidity Metric
  119. Modeling the Effect of Chronic Schistosomiasis on Childhood Development and the Potential for Catch-Up Growth with Different Drug Treatment Strategies Promoted for Control of Endemic Schistosomiasis
  120. Flukes (Liver, Lung, and Intestinal)
  121. Schistosomiasis (Schistosoma)